123 Participants Needed

Exercise for Parkinson's Disease

(HI-LITE Trial)

ME
JR
Overseen ByJoe R Nocera, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
Must be taking: Antiparkinsonian medications
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine the best exercise routine for people with mid-stage Parkinson's disease (PD). It compares high-volume dance exercises, moderate-volume dance exercises, and moderate-volume walking to identify which method best improves movement, physical activity levels, and overall health. Participants with PD symptoms such as stiffness, slow movement, or tremors, who experience relief from their medications, might be suitable for this trial. As an unphased trial, it offers participants the chance to contribute to valuable research that could improve exercise recommendations for Parkinson's disease.

Will I have to stop taking my current medications?

The trial requires participants to be observed while not taking their antiparkinsonian medications to avoid certain side effects and fluctuations. This means you will need to stop these medications during specific observation periods.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that partnered dance aerobic exercise (PDAE) is generally well-tolerated by people with Parkinson's disease. Studies have found that PDAE can reduce "OFF-time" (when medication isn't working well) and improve quality of life. No major safety issues have been reported for PDAE, whether done in high or moderate amounts, suggesting it is a safe option for people with Parkinson's.

For moderate volume walking (MV-WALK), research indicates that moderate aerobic exercise, like walking, helps improve balance and walking ability. It is considered safe for people with Parkinson's, with no major reports of negative effects. Walking is often recommended for its overall health benefits and easy-to-manage intensity.

Both partnered dance and walking exercises are safe, with research supporting their use in improving symptoms and overall well-being in people with Parkinson's.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments for Parkinson's Disease because they explore innovative, non-pharmacological methods to improve movement and balance. Unlike standard treatments that often rely on medication to manage symptoms, these approaches use dance and walking as interactive, physical therapies. The High Volume Partnered Dance Aerobic Exercise (HV-PDAE) and the Moderate Volume Partnered Dance Aerobic Exercise (MV-PDAE) offer unique social and rhythmic elements, with dance adapted specifically for older adults with balance impairments. Participants engage in Argentine tango-inspired movements with partners, which can enhance coordination. Meanwhile, the Moderate Volume Walking (MV-WALK) arm provides a structured yet flexible walking routine aimed at improving gait. Collectively, these methods emphasize physical engagement and social interaction, which can provide holistic benefits beyond those offered by typical medical interventions.

What evidence suggests that this trial's treatments could be effective for Parkinson's disease?

This trial will compare different exercise interventions for Parkinson's disease. Studies have shown that partnered dance aerobic exercise (PDAE) reduces OFF-time in people with Parkinson's disease (PD). OFF-time refers to periods when symptoms are not well-controlled. In this trial, participants may receive either high-volume or moderate-volume PDAE. Research indicates that both high and moderate amounts of PDAE improve quality of life and movement abilities in people with PD. Evidence suggests that PDAE is more effective than simple walking programs for these improvements. However, another group in this trial will engage in moderate-volume walking, which also benefits participants by improving walking speed and gait. Regular moderate-intensity walking can help manage the disease and increase physical activity levels. Each exercise type in this trial has its own strengths in managing PD symptoms.23456

Who Is on the Research Team?

ME

Madeleine E. Hackney, PhD

Principal Investigator

Atlanta VA Medical and Rehab Center, Decatur, GA

Are You a Good Fit for This Trial?

This trial is for veterans over 40 with moderate Parkinson's disease (stages 2 to 3), who can walk at least 10 feet and have a certain level of cognitive function. They must not have severe depression, major psychiatric illness, significant hearing loss, or serious heart conditions. Participants should benefit from Parkinson's medication and be able to commit to the study duration without long absences.

Inclusion Criteria

I can walk at least 10 feet by myself or with help.
Your vision with glasses or contacts is better than 20/70 in your better eye.
My Parkinson's disease is at a moderate stage.
See 6 more

Exclusion Criteria

Your hearing sensitivity at certain frequencies is worse than 40 decibels.
I have not been treated for major depression or serious mental illness.
I have had a stroke or traumatic brain injury in the past.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in Partnered Dance Aerobic Exercise (PDAE) or Walking for 52 weeks, with varying frequency and duration based on group assignment

52 weeks
HV-PDAE: 5 times a week for 90 minutes for 3 weeks initially, then every 4 weeks; MV-PDAE and MV-WALK: twice-weekly for 65 minutes

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • HV-PDAE: High Volume Partnered Dance Aerobic Exercise
  • MV-PDAE: Moderate Volume Partnered Dance Aerobic Exercise
  • MV-WALK: Moderate Volume Walking
Trial Overview The study compares two exercise regimens for those with mid-stage Parkinson's: one involves high volume dance aerobic exercise once a month followed by three weeks rest; the other is moderate exercise done consistently every week. The effects on walking speed, physical activity levels, blood biochemistry, and blood vessel stiffness will be measured.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: HV-PDAE: High Volume Partnered Dance Aerobic ExerciseExperimental Treatment1 Intervention
Group II: MV-PDAE: Moderate Volume Partnered Dance Aerobic ExerciseActive Control1 Intervention
Group III: MV-WALK: Moderate Volume WalkingActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

Published Research Related to This Trial

A 12-week study involving 11 participants with Parkinson's disease showed that both tango dance and a mixed styles dance intervention improved balance and endurance, but tango specifically improved mobility and motor signs.
The findings suggest that tango dance may be more effective than the Dance for Parkinson's model in enhancing certain motor functions in people with Parkinson's disease, highlighting the importance of comparing different exercise interventions for optimal treatment.
Differential Effects of Tango Versus Dance for PD in Parkinson Disease.McNeely, ME., Mai, MM., Duncan, RP., et al.[2020]
A survey of 64 Parkinson's Disease patients revealed that 67% exercised at least twice a week, with walking being the most common form of exercise, and 97% reported improvements in their symptoms due to exercise.
Patients who exercised in groups experienced greater symptomatic improvements compared to those who exercised alone, highlighting the potential added benefits of social interaction and cognitive engagement in group activities like dance therapy.
Self-Reported Exercise Trends in Parkinson's Disease Patients.Raje, P., Ning, S., Branson, C., et al.[2019]
Individuals with Parkinson disease (PD) who take at least 4200 steps daily are significantly more likely to meet physical activity guidelines, being 23 times more likely than those who take fewer steps.
High-intensity treadmill exercise effectively increases daily steps and moderate-to-vigorous physical activity in less active individuals with PD, but these increases do not correlate with improvements in fitness.
Physical Activity in De Novo Parkinson Disease: Daily Step Recommendation and Effects of Treadmill Exercise on Physical Activity.Handlery, R., Stewart, JC., Pellegrini, C., et al.[2021]

Citations

NCT06088355 | Moderate Versus High Volume Light- ...Veterans with mid to later stage Parkinson's disease (PD) may not be able to work out as hard as they need to, to prevent brain cell loss.
Rationale and Design of the PAIRED Trial: Partnered Dance ...Our data suggest that partnered dance aerobic exercise (PDAE) reduces OFF-time on the Movement Disorders Society Unified Parkinson Disease Rating Scale-IV (MDS- ...
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40791686/
Three Months of Partnered Dance Aerobic Exercise Can ...PDAE is superior to WALK and is an effective adjunctive therapy to help improve OFF-time and QOL in individuals with PD after three months.
Three Months of Partnered Dance Aerobic Exercise ...Introduction: Parkinson's Disease (PD) is commonly treated with the dopamine precursor, levodopa, which is used in antiparkinsonian therapy.
Partnered Dance Aerobic Exercise as a Neuroprotective, ...Our data suggest that partnered dance aerobic exercise (PDAE) reduces OFF-time on the Movement Disorders Society Unified Parkinson Disease ...
NCT04122690 | Partnered Dance Aerobic Exercise as a ...However, the investigators' research has shown that partnered dance-aerobic exercise (PDAE) reduces OFF-time on the official test for OFF-time of the Movement ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security